FDA Adverse Event Injury Summary report: N

LIQUIBAND SURGICAL S

MDR report key: 11783714 · Received May 6, 2021

Report

Report Number
9617175-2021-00022
Event Type
Injury
Date Received
May 6, 2021
Date of Event
March 27, 2021
Report Date
June 24, 2021
Manufacturer
ADVANCED MEDICAL SOLUTIONS LTD
Product Code
MPN
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 0

WE CANNOT CONFIRM OR DENY THAT LIQUIBAND SURGICAL S CAUSED A SERIOUS INJURY. THERE IS A SMALL PERCENTAGE OF THE POPULATION WITH A NATURAL SENSITIVITY TO CYANOACRYLATE ADHESIVE. THIS IS INDICATED IN THE INSTRUCTIONS FOR USE (IFU).

Description of Event or Problem · 0

ALLERGIC SKIN REACTION (ITCHING, REDNESS AND PAPULES) OCCURRED 3 DAYS AFTER SURGERY ON HERNIATED DISC, AROUND THE SCAR, IN A WOMAN WITH A HISTORY OF ALLERGY (MEDICINAL PRODUCT). FOLLOW-UP INFORMATION RECEIVED: AT THE FOLLOW-UP VISIT, THE WOUND WAS WELL CLOSED BUT SOME RESIDUAL BLISTER MARKS WERE NOTICED. ACCORDING TO THE NEUROSURGEON, THE OUTCOME WAS RESOLVED WITH LOCAL CORTICOSTEROIDS AND ORAL ANTIHISTAMINES IN 15 DAYS.

Additional Manufacturer Narrative · 1

WE CANNOT CONFIRM OR DENY THAT LIQUIBAND SURGICAL S CAUSED A SERIOUS INJURY. THERE IS A SMALL PERCENTAGE OF THE POPULATION WITH A NATURAL SENSITIVITY TO CYANOACRYLATE ADHESIVE. THIS IS INDICATED IN THE INSTRUCTIONS FOR USE (IFU).

Description of Event or Problem · 1

ALLERGIC SKIN REACTION (ITCHING, REDNESS AND PAPULES) OCCURRED 3 DAYS AFTER SURGERY ON A HERNIATED DISC, AROUND THE SCAR. PATIENT TREATED WITH ORAL ANTIHISTAMINICS + LOCAL CORTICOSTEROID.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
682130 LIQUIBAND SURGICAL S TOPICAL SKIN ADHESIVE MPN ADVANCED MEDICAL SOLUTIONS LTD LBS-S 0001

Patients

Seq Age Sex Outcome Treatment
1 50 YR Other